{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:08:41Z","timestamp":1791407321645,"version":"4.3.3"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Glucagon-like peptide-1 receptor agonists (GLP-1RAs) were developed as insulinotropic and anti-hyperglycemic agents for the treatment of type 2 diabetes, but their neurotrophic and neuroprotective activities have been receiving increasing attention. Myelin plays a key role in the functional maintenance of the central and peripheral nervous systems, and recent <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic> studies have shed light on the beneficial effects of GLP-1RAs on the formation and protection of myelin. In this article, we describe the potential efficacy of GLP-1RAs for the induction of axonal regeneration and remyelination following nerve lesions and the prevention and alleviation of demyelinating disorders, particularly multiple sclerosis.<\/jats:p>","DOI":"10.3389\/fcell.2022.950623","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T16:46:29Z","timestamp":1657125989000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Glucagon-Like Peptide-1 Receptor Agonists as Potential Myelination-Inducible and Anti-Demyelinating Remedies"],"prefix":"10.3389","volume":"10","author":[{"given":"Kazunori","family":"Sango","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuka","family":"Takaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideji","family":"Yako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s10787-022-00956-6","article-title":"Neuroprotective Effect of Liraglutide in an Experimental Mouse Model of Multiple Sclerosis: Role of AMPK\/SIRT1 Signaling and NLRP3 Inflammasome","volume":"30","author":"Ammar","year":"20222022","journal-title":"Inflammopharmacol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.drudis.2016.01.013","article-title":"The Glucagon-like Peptide 1 (GLP) Receptor as a Therapeutic Target in Parkinson's Disease: Mechanisms of Action","volume":"21","author":"Athauda","year":"2016","journal-title":"Drug Discov. Today"},{"key":"B3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/978-981-32-9636-7_16","article-title":"Roads to Formation of Normal Myelin Structure and Pathological Myelin Structure","volume":"1190","author":"Bando","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/brain\/awx044","article-title":"Insulin Resistance and Exendin-4 Treatment for Multiple System Atrophy","volume":"140","author":"Bassil","year":"2017","journal-title":"Brain"},{"key":"B5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/bc.bc_21_21","article-title":"Exendin-4 for Parkinson's Disease","volume":"7","author":"Borlongan","year":"2021","journal-title":"Brain Circ."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.3390\/ijms20071584","article-title":"Dulaglutide Modulates the Development of Tissue-Infiltrating Th1\/Th17 Cells and the Pathogenicity of Encephalitogenic Th1 Cells in the Central Nervous System","volume":"20","author":"Chiou","year":"2019","journal-title":"Ijms"},{"key":"B7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3727\/096368914x678508","article-title":"The Potential Therapeutic Applications of Olfactory Ensheathing Cells in Regenerative Medicine","volume":"23","author":"Chou","year":"2014","journal-title":"Cell. Transpl."},{"key":"B8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3389\/fphar.2016.00433","article-title":"Glucagon-like Peptide-1 Analog, Liraglutide, Delays Onset of Experimental Autoimmune Encephalitis in Lewis Rats","volume":"7","author":"DellaValle","year":"2016","journal-title":"Front. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell. Metab."},{"key":"B10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13063-019-3259-x","article-title":"Evaluating the Effects of the Novel GLP-1 Analogue Liraglutide in Alzheimer's Disease: Study Protocol for a Randomised Controlled Trial (ELAD Study)","volume":"20","author":"Femminella","year":"2019","journal-title":"Trials"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0141921","DOI":"10.1371\/journal.pone.0141921","article-title":"Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats","volume":"10","author":"Fujita","year":"2015","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1007\/s13311-021-01088-5","article-title":"Therapeutic Potential of a Novel Glucagon-like Peptide-1 Receptor Agonist, NLY01, in Experimental Autoimmune Encephalomyelitis","volume":"18","author":"Gharagozloo","year":"2021","journal-title":"Neurotherapeutics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fendo.2020.00178","article-title":"GLP-1 Analogs and DPP-4 Inhibitors in Type 2 Diabetes Therapy: Review of Head-To-Head Clinical Trials","volume":"11","author":"Gilbert","year":"2020","journal-title":"Front. Endocrinol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/glia.23755","article-title":"Disrupting Insulin Signaling in Schwann Cells Impairs Myelination and Induces a Sensory Neuropathy","volume":"68","author":"Hackett","year":"2020","journal-title":"Glia"},{"key":"B15","doi-asserted-by":"publisher","first-page":"17106","DOI":"10.1074\/jbc.m114.631291","article-title":"Hyperglycemia Promotes Schwann Cell De-differentiation and De-myelination via Sorbitol Accumulation and Igf1 Protein Down-Regulation","volume":"290","author":"Hao","year":"2015","journal-title":"J. Biol. Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1476-5381.2009.00486.x","article-title":"Glucagon-like Peptide 1 Receptor Stimulation as a Means of Neuroprotection","volume":"159","author":"Harkavyi","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.2337\/db10-1462","article-title":"Beneficial Effects of Exendin-4 on Experimental Polyneuropathy in Diabetic Mice","volume":"60","author":"Himeno","year":"2011","journal-title":"Diabetes"},{"key":"B18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/bph.15508","article-title":"Protective Properties of GLP-1 and Associated Peptide Hormones in Neurodegenerative Disorders","volume":"179","author":"H\u00f6lscher","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1016\/j.clinph.2021.05.033","article-title":"Effect of Exenatide on Peripheral Nerve Excitability in Type 2 Diabetes","volume":"132","author":"Issar","year":"2021","journal-title":"Clin. Neurophysiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"120267","DOI":"10.1016\/j.jns.2022.120267","article-title":"Neuro-ophthalmological Manifestations of Wolfram Syndrome: Case Series and Review of the Literature","volume":"437","author":"Kabanovski","year":"2022","journal-title":"J. Neurological Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"17027","DOI":"10.1038\/s41598-021-96418-0","article-title":"The GLP-1 Receptor Agonist, Liraglutide, Fails to Slow Disease Progression in SOD1G93A and TDP-43Q331K Transgenic Mouse Models of ALS","volume":"11","author":"Keerie","year":"2021","journal-title":"Sci. Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.4103\/1673-5374.205105","article-title":"Exenatide Promotes Regeneration of Injured Rat Sciatic Nerve","volume":"12","author":"Kuyucu","year":"2017","journal-title":"Neural Regen. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1177\/2050640620925968","article-title":"Liraglutide Accelerates Colonic Transit in People with Type 1 Diabetes and Polyneuropathy: A Randomised, Double\u2010blind, Placebo\u2010controlled Trial","volume":"8","author":"Langmach Wegeberg","year":"2020","journal-title":"United Eur. Gastroenterol. J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1007\/s12035-017-0550-2","article-title":"Activation of Glucagon-like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses","volume":"55","author":"Lee","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1096\/fj.04-1581fje","article-title":"Phosphatidylinositol 3\u2010kinase and Akt Effectors Mediate Insulin\u2010like Growth factor\u2010I Neuroprotection in Dorsal Root Ganglia Neurons","volume":"18","author":"Leinninger","year":"2004","journal-title":"FASEB J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e32008","DOI":"10.1371\/journal.pone.0032008","article-title":"Exendin-4 Ameliorates Motor Neuron Degeneration in Cellular and Animal Models of Amyotrophic Lateral Sclerosis","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/j.1476-5381.2011.01272.x","article-title":"Neuroprotective Effect of the Glucagon-like Peptide-1 Receptor Agonist, Synthetic Exendin-4, in Streptozotocin-Induced Diabetic Rats","volume":"164","author":"Liu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.3892\/ijmm.2018.3509","article-title":"GLP-1R A-gonists A-meliorate P-eripheral N-erve D-ysfunction and I-nflammation via P-38 MAPK\/NF-\u03baB S-ignaling P-athways in S-treptozotocin-induced D-iabetic R-ats","volume":"41","author":"Ma","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/978-981-32-9636-7_22","article-title":"Schwann Cells as Crucial Players in Diabetic Neuropathy","volume":"1190","author":"Naruse","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3390\/ijms22031031","article-title":"Aldose Reductase and the Polyol Pathway in Schwann Cells: Old and New Problems","volume":"22","author":"Niimi","year":"2021","journal-title":"Ijms"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e13631","DOI":"10.1111\/nmo.13631","article-title":"PI 3-kinase- and ERK-MAPK-dependent Mechanisms Underlie Glucagon-like Peptide-1-Mediated Activation of Sprague Dawley Colonic Myenteric Neurons","volume":"31","author":"O'Brien","year":"2019","journal-title":"Neurogastroenterol. Motil."},{"key":"B32","doi-asserted-by":"publisher","first-page":"6724","DOI":"10.1523\/jneurosci.5520-03.2004","article-title":"Opposing Extracellular Signal-Regulated Kinase and Akt Pathways Control Schwann Cell Myelination","volume":"24","author":"Ogata","year":"2004","journal-title":"J. Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/s00415-020-10213-x","article-title":"Polyradiculoneuropathy Induced by Immune Checkpoint Inhibitors: a Case Series and Review of the Literature","volume":"268","author":"Okada","year":"2021","journal-title":"J. Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"538695","DOI":"10.3389\/fneur.2020.538695","article-title":"Central Nervous System Demyelination Associated with Immune Checkpoint Inhibitors: Review of the Literature","volume":"11","author":"Oliveira","year":"2020","journal-title":"Front. Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2020.04.017","article-title":"Exendin-4 Promotes Schwann Cell Proliferation and Migration via Activating the Jak-STAT Pathway after Peripheral Nerve Injury","volume":"437","author":"Pan","year":"2020","journal-title":"Neuroscience"},{"key":"B36","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jcrc.2021.05.020","article-title":"Critically Ill Patients with Severe Immune Checkpoint Inhibitor Related Neurotoxicity: A Multi-Center Case Series","volume":"65","author":"Rajendram","year":"2021","journal-title":"J. Crit. Care"},{"key":"B37","doi-asserted-by":"publisher","first-page":"5162","DOI":"10.3390\/ijms23095162","article-title":"Proteomics in Multiple Sclerosis: the Perspective of the Clinician","volume":"23","author":"Sandi","year":"2022","journal-title":"Ijms"},{"key":"B38","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00418-012-0934-3","article-title":"Myelination in Coculture of Established Neuronal and Schwann Cell Lines","volume":"137","author":"Sango","year":"2012","journal-title":"Histochem. Cell. Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fendo.2017.00012","article-title":"Impaired Axonal Regeneration in Diabetes. Perspective on the Underlying Mechanism from In Vivo and In Vitro Experimental Studies","volume":"8","author":"Sango","year":"2017","journal-title":"Front. Endocrinol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/jnr.22605","article-title":"Spontaneously Immortalized Schwann Cells from Adult Fischer Rat as a Valuable Tool for Exploring Neuron-Schwann Cell Interactions","volume":"89","author":"Sango","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1038\/s41598-021-81768-6","article-title":"Liraglutide, 7,8-DHF and Their Co-treatment Prevents Loss of Vision and Cognitive Decline in a Wolfram Syndrome Rat Model","volume":"11","author":"Seppa","year":"2021","journal-title":"Sci. Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1007\/s10072-021-05328-6","article-title":"Dysregulation of IGF-1\/GLP-1 Signaling in the Progression of ALS: Potential Target Activators and Influences on Neurological Dysfunctions","volume":"42","author":"Shandilya","year":"2021","journal-title":"Neurol. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"172835","DOI":"10.1016\/j.ejphar.2019.172835","article-title":"Therapeutic Efficacy of Arginine-Rich Exenatide on Diabetic Neuropathy in Rats","volume":"866","author":"Shekunova","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"106022","DOI":"10.1016\/j.appet.2022.106022","article-title":"A Comparative Transcriptomic Analysis of Glucagon-like Peptide-1 Receptor- and Glucose-dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus","volume":"174","author":"Smith","year":"2022","journal-title":"Appetite"},{"key":"B45","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/cns.13791","article-title":"Liraglutide Attenuate Central Nervous Inflammation and Demyelination through AMPK and Pyroptosis\u2010related NLRP3 Pathway","volume":"28","author":"Song","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.3390\/ijms22062971","article-title":"Exendin-4 Promotes Schwann Cell Survival\/migration and Myelination In Vitro","volume":"22","author":"Takaku","year":"2021","journal-title":"Ijms"},{"key":"B47","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00418-018-1649-x","article-title":"Establishment of a Myelinating Co-culture System with a Motor Neuron-like Cell Line NSC-34 and an Adult Rat Schwann Cell Line IFRS1","volume":"149","author":"Takaku","year":"2018","journal-title":"Histochem. Cell. Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3389\/fncel.2018.00437","article-title":"Inhibition of RhoA-Subfamily GTPases Suppresses Schwann Cell Proliferation through Regulating AKT Pathway rather Than ROCK Pathway","volume":"12","author":"Tan","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"111819","DOI":"10.1016\/j.biopha.2021.111819","article-title":"Liraglutide Modulates Olfactory Ensheathing Cell Migration with Activation of ERK and Alteration of the Extracellular Matrix","volume":"141","author":"Tseng","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/jnc.13439","article-title":"The Dipeptidyl Peptidase IV Inhibitor Vildagliptin Suppresses Development of Neuropathy in Diabetic Rodents: Effects on Peripheral Sensory Nerve Function, Structure and Molecular Changes","volume":"136","author":"Tsuboi","year":"2016","journal-title":"J. Neurochem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00418-015-1333-3","article-title":"Neurotrophic and Neuroprotective Properties of Exendin-4 in Adult Rat Dorsal Root Ganglion Neurons: Involvement of Insulin and RhoA","volume":"144","author":"Tsukamoto","year":"2015","journal-title":"Histochem. Cell. Biol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e047993","DOI":"10.1136\/bmjopen-2020-047993","article-title":"Exenatide once Weekly over 2 Years as a Potential Disease-Modifying Treatment for Parkinson's Disease: Protocol for a Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled, Phase 3 Trial: The 'Exenatide-PD3' Study","volume":"11","author":"Vijiaratnam","year":"2021","journal-title":"BMJ Open"},{"key":"B53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1155\/2013\/315848","article-title":"Therapeutic Effect of Exendin-4, a Long-Acting Analogue of Glucagon-like Peptide-1 Receptor Agonist, on Nerve Regeneration after the Crush Nerve Injury","volume":"2013","author":"Yamamoto","year":"2013","journal-title":"BioMed Res. Int."},{"key":"B54","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/978-981-32-9636-7_14","article-title":"Multiple Sclerosis","volume":"1190","author":"Yamasaki","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00207454.2021.1924707","article-title":"The Pleiotropic of GLP-1\/GLP-1R axis in Central Nervous System Diseases","volume":"2021","author":"Zhang","year":"2021","journal-title":"Int. J. Neurosci."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.950623\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T16:46:32Z","timestamp":1657125992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.950623\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":55,"alternative-id":["10.3389\/fcell.2022.950623"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2022.950623","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"article-number":"950623"}}